Showing results (1661-1670 of 1,709) with videos related to
Sort By:
Pageof 171
Environment International|June 28, 2026
Joint associations between gestational environmental chemical mixtures and child behavioral outcomesJagadeesh Puvvula, Wei-Ting Hwang, Lawrence McCandless, et al.Nature Neuroscience|July 7, 2014
Noninvasive optical inhibition with a red-shifted microbial rhodopsinAmy S Chuong, Mitra L Miri, Volker Busskamp, et al.BMJ Open|October 21, 2022
Cohort profile: the ECHO prenatal and early childhood pathways to health consortium (ECHO-PATHWAYS)Kaja Z LeWinn, Catherine J Karr, Marnie Hazlehurst, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2020
Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized TherapyVignesh Narasimhan, Josephine A Wright, Michael Churchill, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepinesRebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.The New England Journal of Medicine|September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2026
Outcomes and disease activity during and after pregnancy in Asian women with MOGADJae-Won Hyun, De-Cai Tian, Yun Xu, et al.Communications Medicine|January 22, 2024
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysisAbrar Ahmad, Lee-Ling Lim, Mario Luca Morieri, et al.Journal of Medicinal Chemistry|February 17, 2006
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxietyMichael G N Russell, Robert W Carling, Leslie J Street, et al.Blood Cancer Journal|January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.Pageof 171